Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies

Samankaltaisia teoksia

• Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8(+) T cells in myeloid malignancies
  Tekijä: Rezvani, Katayoun, et al.
  Julkaistu: (2011)
• Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy
  Tekijä: Rezvani, Katayoun, et al.
  Julkaistu: (2011)
• Ex vivo characterization of polyclonal memory CD8(+) T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
  Tekijä: Rezvani, Katayoun, et al.
  Julkaistu: (2009)
• High PR3 or ELA2 expression by CD34(+) cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effects
  Tekijä: Yong, Agnes S. M., et al.
  Julkaistu: (2007)
• Graft-versus-leukemia effects associated with detectable Wilms tumor-1–specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
  Tekijä: Rezvani, Katayoun, et al.
  Julkaistu: (2007)